MedTrace Logo

Impact in the Medical Care Among the Rheumatic Diseases Patients in a Hospital in México During COVID-19 Pandemic

NCT04557358 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 670

Last updated 2022-09-28

No results posted yet for this study

Summary

The National Institute of Medical Sciences and Nutrition is a national reference center for rheumatic diseases that belongs to The National Institutes of Health, and has Federal founding. More than 8,000 patients with a wide variety of rheumatologic diagnosis receive medical care.

On March 2020, the WHO announced COVID-19 outbreak a pandemic. The first case was registered in Mexico on February 2020. In March 2020, the Mexican Government requested that our Institution should restrict health care to exclusively COVID-19 patients; accordingly, outpatient consultations were, and up to August 2020 still, hold on.

Meanwhile, when possible, the Department of Immunology and Rheumatology has implemented an "on-demand", non-organized patient´s health care, through email and phone contact; nonetheless, and due to the middle-low socioeconomic status of most of our patients and limited technical resources available at our Institution, the attempt has been challenging.

Conditions

Interventions

OTHER

COVID-19 survey

A questionnaire locally developed to explore access to medical care and to medications, access to communication with their primary rheumatologist, and patients risk perception about COVID-19 disease

OTHER

RAPID-3

The instrument measures function, pain, and patient global estimate of status, with correspond to activity disease

OTHER

WHOQOL-BREF

The instrument measures the patient´s quality of life (4 dimensions: physics, phycological, social, and environment)

OTHER

DASS-21 instrument (depression and anxiety)

The instrument measures the presence of depression and anxiety

OTHER

IER-R (posttraumatic stress)

The instrument measures the presence of posttraumatic stress

Sponsors & Collaborators

  • National Institute of Medical Sciences and Nutrition, Salvador Zubiran

    lead OTHER

Principal Investigators

  • Virginia Pascual-Ramos, Dr. · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04557358 on ClinicalTrials.gov